<?xml version="1.0" encoding="UTF-8"?>
<p>In summary, we have established the first stable neonatal mice model of CVA4 infection which displayed consistent pathological changes and demonstrated the immunogenicity of an inactivated CVA4 whole-virus vaccine. IFN-Î±2a and antiserum had effective anti-CVA4 effects 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic>. This neonatal murine model lays a foundation for studying the pathogenesis of CVA4 and for evaluating the effectiveness of vaccines and screening of antiviral drugs.
</p>
